Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,711
Closed -$388K 1824
2026
Q1
$388K Buy
+11,711
New +$381K ﹤0.01% 957
2025
Q2
Sell
-10,976
Closed -$203K 1529
2025
Q1
$203K Buy
+10,976
New +$198K 0.01% 1292
2024
Q4
Sell
-26,871
Closed -$377K 1683
2024
Q3
$377K Sell
26,871
-3,555
-12% -$39.3K 0.01% 1436
2024
Q2
$220K Buy
30,426
+16,877
+125% +$115K ﹤0.01% 1632
2024
Q1
$109K Sell
13,549
-17,028
-56% -$152K ﹤0.01% 1594
2023
Q4
$209K Buy
30,577
+13,075
+75% +$72.7K 0.01% 1407
2023
Q3
$87.5K Buy
+17,502
New +$121K ﹤0.01% 1546

Other funds holding AXGN

Centiva Capital's AXGN Position: Q2 2026 in Review

Centiva Capital sold out of Axogen (AXGN) in Q2 2026, closing a stake of 11,711 shares — an estimated $388K sold.

Centiva Capital first reported a position in AXGN in Q3 2023 and held it in 7 quarters. The position peaked at $388K in Q1 2026. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Centiva Capital reported no remaining Axogen position as of Q2 2026 after selling out during the quarter.
  • Centiva Capital sold 11,711 Axogen shares in Q2 2026, an estimated $388K.
  • Centiva Capital first reported a position in Axogen in Q3 2023 and held it in 7 quarters.
  • Centiva Capital's Axogen position peaked at $388K in Q1 2026.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.